Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease

被引:52
|
作者
Ecder, T
Melnikov, VY
Stanley, M
Korular, D
Lucia, MS
Schrier, RW
Edelstein, CL
机构
[1] Univ Colorado, Sch Med, Dept Med, Div Renal Dis & Hypertens, Denver, CO 80262 USA
[2] Univ Colorado, Sch Med, Dept Pathol, Denver, CO 80262 USA
关键词
caspase-3; Bcl-2; apoptosis; polycystic kidneys; Han : SPRD rats; ADPKD; progressive renal disease;
D O I
10.1046/j.1523-1755.2002.00250.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Apoptosis is a characteristic feature of human autosomal-dominant polycystic kidney disease (ADPKD). The Han:Sprague-Dawley (SPRD) rat model closely resembles human ADPKD and presents an opportunity to investigate the apoptotic pathway in the pathogenesis of this disease. Methods. Han:SPRD rats were studied during the early stages of ADPKD (newborn, 2 and 6 weeks old). Apoptotic cells were detected by the TUNEL (Tdt-mediated dUTP nick end-labeling) assay. Caspase-3 activity was measured using the fluorescent substrate DEVD-AMC and cleavage of poly (ADP-ribose) polymerase [PAR-P]. Expression of pro- and anti-apoptotic B-cell lymphoma (Bcl-2) proteins was detected on Western blot analysis. Results. TUNEL (+) cells, caspase-3 activity and caspase-mediated PARP breakdown were significantly increased in 2-week-old heterozygous (Cy/+) and homozygous (Cy/Cy) rat kidneys compared to normal littermate controls. In Cy/+ rat kidneys, decreased expression of anti-apoptotic Bcl-X-L coincided with increased caspase-3 activity at 2 weeks of age while expression of Bcl-2, another anti-apoptotic protein, increased at 6 weeks of age. In Cy/Cy rat kidneys, decreased expression of Bcl-X-L and increased expression of Bcl-2 was present at 2 weeks of age. Pro-apoptotic Bax and Bad expression was unchanged at 2 weeks of age in both Cy/+ and Cy/Cy rat kidneys. Conclusions. Activation of caspase-3 and dysregulation of the balance between pro- and anti-apoptotic Bcl-2 family members, specifically a down-regulation of anti-apoptotic Bcl-X-L, correlates with increased apoptosis in polycystic Han:SPRD rat kidneys.
引用
收藏
页码:1220 / 1230
页数:11
相关论文
共 50 条
  • [1] TGF-β1, SMAD 2/3 AND BCL-2 PROTEINS AND APOPTOSIS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
    Lhee, Hyun Young
    Lee, Kyu-Beck
    Kim, Hyang
    Che, Seung Wan
    Park, Moon Hyang
    NEPHROLOGY, 2005, 10 : A159 - A159
  • [2] Autosomal-dominant polycystic kidney disease
    Thomas, Merlin C.
    NEPHROLOGY, 2007, 12 : S52 - S56
  • [3] Autosomal-Dominant Polycystic Kidney Disease
    Kittisupamongkol, Weekitt
    CHEST, 2009, 135 (06) : 1697 - 1698
  • [4] Autosomal-dominant polycystic Kidney Disease
    Wuethrich, R. P.
    NEPHROLOGE, 2015, 10 (05): : 376 - 378
  • [5] Angiogenesis in autosomal-dominant polycystic kidney disease
    Bello-Reuss, E
    Holubec, K
    Rajarman, S
    KIDNEY INTERNATIONAL, 2001, 60 (01) : 37 - 45
  • [6] AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE
    GABOW, PA
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (05): : 332 - 342
  • [7] Autosomal-Dominant Polycystic Kidney Disease Response
    Li, Howard Y.
    Cosgrove, Gregory P.
    Swigris, Jeffrey J.
    CHEST, 2009, 135 (06) : 1698 - 1698
  • [8] AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE
    SAGGARMALIK, AK
    JEFFERY, S
    PATTON, MA
    BRITISH MEDICAL JOURNAL, 1994, 308 (6938): : 1183 - 1184
  • [9] Hypertension in autosomal-dominant polycystic kidney disease (ADPKD)
    Sans-Atxer, Laia
    Torra, Roser
    Fernandez-Llama, Patricia
    CLINICAL KIDNEY JOURNAL, 2013, 6 (05) : 457 - 463
  • [10] Treatment prospects for autosomal-dominant polycystic kidney disease
    Qian, Q
    Harris, PC
    Torres, VE
    KIDNEY INTERNATIONAL, 2001, 59 (06) : 2005 - 2022